Holdings

Davern Capital Partners, LP

As of Sep 30, 2026, Davern Capital Partners, LP reported 16 positions worth US$457M. Largest: BioNTech SE, Insmed Incorporated and Roivant Sciences Ltd. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
BioNTech SE682KUS$67.1MnewSep 30, 2026
Insmed Incorporated496KUS$56.6M−63,777Sep 30, 2026
Roivant Sciences Ltd.1.47MUS$53.9M−460KSep 30, 2026
Ionis Pharmaceuticals, Inc.1.09MUS$48.5M+288KSep 30, 2026
argenx SE37,597US$36.1MnewSep 30, 2026
Regeneron Pharmaceuticals, Inc.40,661US$30.8M−51,979Sep 30, 2026
Natera, Inc.63,200US$26.1M−55,775Sep 30, 2026
Abivax SA219KUS$21.7MnewSep 30, 2026
Vera Therapeutics, Inc.628KUS$20.3M+129KSep 30, 2026
Mineralys Therapeutics, Inc.695KUS$17.5M−164KSep 30, 2026